Literature DB >> 26596352

The impact of covariate misclassification using generalized linear regression under covariate-adaptive randomization.

Liqiong Fan1, Sharon D Yeatts1, Bethany J Wolf1, Leslie A McClure2, Magdy Selim3, Yuko Y Palesch1.   

Abstract

Under covariate adaptive randomization, the covariate is tied to both randomization and analysis. Misclassification of such covariate will impact the intended treatment assignment; further, it is unclear what the appropriate analysis strategy should be. We explore the impact of such misclassification on the trial's statistical operating characteristics. Simulation scenarios were created based on the misclassification rate and the covariate effect on the outcome. Models including unadjusted, adjusted for the misclassified, or adjusted for the corrected covariate were compared using logistic regression for a binary outcome and Poisson regression for a count outcome. For the binary outcome using logistic regression, type I error can be maintained in the adjusted model, but the test is conservative using an unadjusted model. Power decreased with both increasing covariate effect on the outcome as well as the misclassification rate. Treatment effect estimates were biased towards the null for both the misclassified and unadjusted models. For the count outcome using a Poisson model, covariate misclassification led to inflated type I error probabilities and reduced power in the misclassified and the unadjusted model. The impact of covariate misclassification under covariate-adaptive randomization differs depending on the underlying distribution of the outcome.

Entities:  

Keywords:  Covariate–adaptive randomization; covariate misclassification; generalized linear regression

Mesh:

Year:  2015        PMID: 26596352      PMCID: PMC5476516          DOI: 10.1177/0962280215616405

Source DB:  PubMed          Journal:  Stat Methods Med Res        ISSN: 0962-2802            Impact factor:   3.021


  16 in total

1.  Comparison of stratification and adaptive methods for treatment allocation in an acute stroke clinical trial.

Authors:  Christopher J Weir; Kennedy R Lees
Journal:  Stat Med       Date:  2003-03-15       Impact factor: 2.373

2.  Covariate-adjusted adaptive randomization in a sarcoma trial with multi-stage treatments.

Authors:  Peter F Thall; J Kyle Wathen
Journal:  Stat Med       Date:  2005-07-15       Impact factor: 2.373

3.  Binomial regression with a misclassified covariate and outcome.

Authors:  Sheng Luo; Wenyaw Chan; Michelle A Detry; Paul J Massman; Rachelle S Doody
Journal:  Stat Methods Med Res       Date:  2012-03-15       Impact factor: 3.021

4.  Addressing methodological challenges in implementing the nursing home pain management algorithm randomized controlled trial.

Authors:  Mary Ersek; Nayak Polissar; Anna Du Pen; Anita Jablonski; Keela Herr; Moni B Neradilek
Journal:  Clin Trials       Date:  2012-08-09       Impact factor: 2.486

5.  Thoracic radiotherapy with or without daily low-dose carboplatin in elderly patients with non-small-cell lung cancer: a randomised, controlled, phase 3 trial by the Japan Clinical Oncology Group (JCOG0301).

Authors:  Shinji Atagi; Masaaki Kawahara; Akira Yokoyama; Hiroaki Okamoto; Nobuyuki Yamamoto; Yuichiro Ohe; Toshiyuki Sawa; Satoshi Ishikura; Taro Shibata; Haruhiko Fukuda; Nagahiro Saijo; Tomohide Tamura
Journal:  Lancet Oncol       Date:  2012-05-22       Impact factor: 41.316

6.  Randomized trial of central nervous system-targeted antiretrovirals for HIV-associated neurocognitive disorder.

Authors:  Ronald J Ellis; Scott Letendre; Florin Vaida; Richard Haubrich; Robert K Heaton; Ned Sacktor; David B Clifford; Brookie M Best; Susanne May; Anya Umlauf; Mariana Cherner; Chelsea Sanders; Craig Ballard; David M Simpson; Cheryl Jay; J Allen McCutchan
Journal:  Clin Infect Dis       Date:  2013-12-18       Impact factor: 9.079

7.  The randomization and stratification of patients to clinical trials.

Authors:  M Zelen
Journal:  J Chronic Dis       Date:  1974-09

8.  Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial.

Authors:  David N Krag; Stewart J Anderson; Thomas B Julian; Ann M Brown; Seth P Harlow; Joseph P Costantino; Takamaru Ashikaga; Donald L Weaver; Eleftherios P Mamounas; Lynne M Jalovec; Thomas G Frazier; R Dirk Noyes; André Robidoux; Hugh Mc Scarth; Norman Wolmark
Journal:  Lancet Oncol       Date:  2010-10       Impact factor: 41.316

9.  Properties of permuted-block randomization in clinical trials.

Authors:  J P Matts; J M Lachin
Journal:  Control Clin Trials       Date:  1988-12

10.  Validity of tests under covariate-adaptive biased coin randomization and generalized linear models.

Authors:  Jun Shao; Xinxin Yu
Journal:  Biometrics       Date:  2013-07-12       Impact factor: 2.571

View more
  1 in total

Review 1.  Central masked adjudication of stroke diagnosis at trial entry offered no advantage over diagnosis by local clinicians: Secondary analysis and simulation.

Authors:  Peter J Godolphin; Trish Hepburn; Nikola Sprigg; Liz Walker; Eivind Berge; Ronan Collins; John Gommans; George Ntaios; Stuart Pocock; Kameshwar Prasad; Joanna M Wardlaw; Philip M Bath; Alan A Montgomery
Journal:  Contemp Clin Trials Commun       Date:  2018-11-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.